Lungpacer Medical, Inc.
StreetZero Signal 67
About Lungpacer Medical, Inc.
Lungpacer Medical, Inc. is a privately held medical device company focused on improving respiratory and critical care medicine. Headquartered in Vancouver, Canada, with US offices in Exton, Pennsylvania, it designs non-surgical, minimally invasive technologies to ventilate patients more safely and effectively. The Lungpacer Diaphragm Pacing Therapy System is the first minimally invasive, temporary transvenous diaphragmatic neurostimulation system for ventilator weaning.
LATEST FUNDINGPrivate Placement
$7.8M
Announced 2026-10-14
TOTAL RAISED$133.45M
IN THE NEWS
EMPLOYEES—
FOUNDED—
HQVancouver, Canada
Industry
Other Health Care
Tags
Medical DeviceRespiratory CareNeurostimulationVentilator Weaning
Key highlights
- Raised $133.45M total across nine rounds with latest being a $12M Convertible Note-II.
- Backed by NEA, KCK Group, and Cardiovascular Research Foundation among eight investors.
- Developing first minimally invasive temporary transvenous diaphragmatic neurostimulation system.
- US operations based in Exton, PA with headquarters in Vancouver, Canada.
- Product targets safer weaning from mechanical ventilation in critical care settings.
Ask StreetZero about Lungpacer Medical, Inc.
Put our AI to work on this deal.
Similar companies
Other Other Health Care deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account